Investing News Moderna Stock Declines Amidst Concerns Over RSV Vaccine Efficacy Drop February 9, 2024
Investing News Moderna Forecasts $4 Billion in 2023 Sales from Private Market for COVID-19 Shots August 3, 2023
Investing News Moderna Stock Falls as Flu Vaccine Misses Early Success Criteria; Study Continues April 11, 2023
Investing News Moderna Stock Fell After CEO Bancel Told Lawmakers COVID Vaccination Price Rises Are Justified March 22, 2023
Investing News Moderna Stock Gains on Positive Data From the Phase III RSV Jab Study January 18, 2023